Arkstone’s Antimicrobial Stewardship Program (ASP) Provides Skilled Nursing Facilities with Advanced Cost Effective Program

Arkstone’s technology now provides tracking, reporting and monitoring of infections across an entire facility to provide the most comprehensive ASP available

Arkstone Medical Solutions, LLC, the leading provider of infectious disease laboratory result interpretations and proactive antimicrobial stewardship, announced the new Antimicrobial Stewardship Monthly Report for even more precise analysis of diagnostic data to enhance existing antimicrobial stewardship programs or provide an ASP for facilities who otherwise do not have a program in place.Arkstone works side-by-side with molecular laboratories, and the physicians they serve, to provide clarity and comprehension of diagnostic data. Through proprietary AI systems, advanced algorithms and machine learning, Arkstone’s OneChoice® decision engine delivers the most optimal treatment regimen with every microbiology result. Arkstone uses a multitude of references such as John Hopkins, CDC and IDSA in combination with infectious disease expertise as well as real-time quality assurance input, in order to provide the most up to date evidence based recommendations. Long term care facilities are utilizing laboratories that partner with Arkstone to take advantage of the advanced antimicrobial stewardship programs provided, along with technology that tracks, records, and monitors infection trends across their facilities.“Although The Centers for Medicare & Medicaid Services (CMS), Centers for Disease Control and Prevention (CDC), and The Joint Commission advocate for these programs, many facilities do not have the expertise and backing to support robust and comprehensive stewardship programs,” says Sol Levi, co-founder and CCO. “ The new Antimicrobial Stewardship Monthly Report provides facilities with exactly what they need to have an optimal ASP and helps fulfill the requirements laid out by CMS and the Joint Commission.The Antimicrobial Stewardship Monthly Report includes month-to-month tracking of infections from many different sources, including respiratory, wound, urine, and GI. The report breaks down the most common types of infections and resistance genes and analyzes this data so that trends are easily visible, allowing for the implementation of proactive surveillance and infection control policies. The reports also contain dynamic ASP checklists that are custom tailored to each sample source so that a facility can be confident that all the necessary measures and steps are being taken. Specific analysis of microbes of interest, such as COVID-19, C-diff, MRSA and influenza are focused on ensuring the right protocols are in place to avoid the spread of disease. In addition to specific drug expertise, quality improvement measures, treatment algorithms, ASP policies, and continuous education are provided as well as monthly educational newsletters.“With the growing spread of antimicrobial resistance, ASP programs are essential to all healthcare facilities,” says Dr. Ari Frenkel, Arkstone’s Chief Science Officer and co-founder. “Our new Antimicrobial Stewardship Monthly Reports are designed to provide the most effective, and proactive ASP available. The fight against antibiotic resistance is a collaborative effort and we cannot win it without every healthcare provider and every healthcare facility actively engaged in this process. We believe this new feature can accomplish just that.”Features of The Arkstone Antimicrobial Stewardship Monthly Report:

  • Data monitoring, tracking and reporting
  • Monthly specimen collection trends
  • Positive result detection ratio analyzed
  • Trends of common infections detected per facility
  • Trends of common resistance genes detected per facility
  • Specific monitoring of concerning pathogens
  • Individual specimen source analysis
  • Lab results summary including OneChoice® recommendations
  • Policies and program implementation
  • Treatment algorithms
  • Infection control recommendations
  • Infection alerts to prevent outbreaks
  • Drug expertise
  • Communication with providers via OneChoice® Report
  • Targeted therapy and clarity on possible specimen contaminates or colonizers
  • Antibiotic recommendations against specific pathogens
  • Education
  • Monthly educational newsletters
  • Common pitfalls in testing and treating infections
  • Statistics regarding common infections in long-term care facilities

News

Latest Insights and Updates

Stay informed with our featured press releases.

View More
November 6, 2025

Arkstone’s AI Clinical Decision Support Helps Treat Over 1 Million Patients

The Arkstone platform has been used by doctors across the USA to diagnose and treat diseases in over 1 million patients, a major milestone reached in October 2025. The milestone underscores Arkstone’s leadership in machine learning (ML) and artificial intelligence (AI)-driven infectious disease clinical guidance and its expanding partnerships across the U.S. and around the world.

Read more
September 10, 2024

Arkstone Announces RightDose, a Groundbreaking Enhancement to Ensure Proper Antimicrobial Prescribing

This innovative feature addresses the complexities healthcare providers face when dosing for different age groups and accommodating reduced renal and hepatic function

Read more
August 24, 2023

Arkstone Medical Solutions Launches Breakthrough OneChoice Report for Microbiology Lab Results

Leading Provider of Laboratory Infectious Disease Reporting Expands Precision-Guided Treatment Recommendations to Cultures and Stains

Read more

Customer Testimonials

Arkstone's solutions have transformed our patient care.

"Clinically, Arkstone has significantly decreased my time until optimal treatment. Thanks for your help saving limbs!"

Peter Smith, DPM

"Successful wound healing requires expertise in the management of bioburdens, biofilms, and microbes. Arkstone's advanced input and patient-specific recommendations have translated to superior results in wound healing and patient satisfaction. This has led to better outcomes, unparalleled medical decision making, and respect among medical professionals in the mid-south."

Stephen A. Rohrer, MSN-RN, APRN, AGACNP-BC

"Our providers are so happy we partnered with Arkstone as now they have in depth and actionable guidance with each lab result."

Andrew Wiseman

"The Arkstone Reports provide recommendations and infection control measures that have significantly improved the way we care for patients. It is truly a unique feature that will revamp our antimicrobial stewardship programs."

Cecilia Arriola‑Wulff, BHCM, LVN

"Arkstone does a great job of identifying pathogens and resistance to certain antibiotics, and we love the fact that the reports use a score to rank treatments that doctors can consider. The Arkstone Report assists our physicians in making wise decisions for antibiotic use and patient care."

Matthew Silver

"When it comes to PCR, results can be complicated. Arkstone is a great clinical tool that can help physicians choose the right regimen for their patients."

Dr. Hemant R. Kade, MD

"After following the Arkstone antibiotic treatment recommendation my patient's wound is healing, the small red area is gone, and the overall redness has decreased indicating the infection is gone."

Dr. Robert M. Woodard, MD
Previous
Next

Take the Next Step, Try OneChoice®

No more guesswork. No more lookup tools. No more inaccuracies and inconsistencies. No more stopping to ask for directions.

Try It Out
Get Started
Hand holding smartphone displaying the OneChoice app.